Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands emerging growth company, filed this Form 8-K on December 11, 2024. The filing reports the extension of the deadline to consummate its initial business combination with United Hydrogen Group Inc.
Key Financial Metrics
- Extension Payment: $227,000 deposited into the trust account for public shareholders.
- Per Share Contribution: $0.033 per public share.
- Promissory Note Principal: $227,000 issued to the Sponsor (Aimei Health Ltd) and United Hydrogen Group Inc.
- Interest Rate: 0% (Non-interest bearing).
- Conversion Price: $10.00 per private unit (if converted prior to business combination).
Material Changes
The Company extended its termination date for the initial business combination by one month, from December 6, 2024, to January 6, 2025. This is the first of up to 12 permitted extensions under the Company's Amended and Restated Articles of Association. The filing text does not provide comparative financial data for prior periods as this is a current event report rather than a periodic financial statement.
Outlook, Risks, and Contingencies
The Promissory Note becomes due and payable upon the consummation of the business combination with United Hydrogen. The payees have the option, but not the obligation, to convert the note into private units immediately prior to closing. The filing does not contain specific management commentary on future revenue or profit guidance, nor does it detail specific risks beyond the standard contingencies associated with completing a business combination.
Investor Verification Checklist
- Verify the new termination date of January 6, 2025, for the business combination.
- Confirm the total trust account balance following the $227,000 deposit.
- Review the full text of the Promissory Note (Exhibit 10.1) for conversion mechanics and default terms.
- Monitor for subsequent filings regarding the remaining 11 potential extensions.